Aromasin for Sale: Sourcing, Pricing and What to Know

Aromasin (exemestane) is a prescription medication in the United States and most countries. Its approved clinical use is adjuvant treatment of breast cancer in postmenopausal women. Off-label use as an aromatase inhibitor in bodybuilding — estrogen control on cycle, PCT support — is widespread but outside the scope of that prescription indication.

Aromasin for sale through a pharmacy requires a valid prescription. In practice, most bodybuilders sourcing exemestane for cycle use are not obtaining it through that channel. Understanding what that means for product quality, dosing accuracy, and what to verify is relevant regardless of how you source it.

This article covers the legal landscape, the difference between pharmaceutical and research-grade product, realistic pricing, and what quality indicators actually matter when evaluating what you have.

The most important distinction when looking at aromasin for sale is whether you are getting pharmaceutical-grade exemestane or a research chemical product.

Pharmaceutical grade: Branded Aromasin (Pfizer) and generic exemestane manufactured for pharmacy distribution are subject to regulatory oversight — GMP manufacturing, third-party testing, confirmed dosing accuracy, and quality control. A 25mg pharmaceutical tablet contains 25mg of exemestane within tight tolerances. This is what clinical trials were run on, and what dosing protocols are derived from.

Research chemical grade: Research chemical (RC) exemestane is manufactured outside pharmaceutical regulatory frameworks and marketed legally in most jurisdictions as a research compound — technically not for human consumption. Quality varies significantly between sources. Some RC suppliers have their products independently tested and publish certificates of analysis (COA). Others do not.

The practical consequence: if you buy aromasin through a research chemical supplier and the stated 25mg tab is actually 15mg or 35mg, your EOD dosing protocol produces different results than expected. This is how people end up with E2 that does not respond predictably to dose adjustments.

For RC exemestane, the minimum standard worth accepting:

A COA issued by the same lab the vendor uses in-house is not independent verification.

Aromasin price varies significantly depending on source type and form factor (tablet vs liquid).

Pharmaceutical — brand: Branded Aromasin through US pharmacy without insurance runs $400–$600 for 30 tablets of 25mg. With insurance for an approved indication, cost-sharing varies but can be near zero. At these prices, most bodybuilders are not sourcing pharmaceutical brand for cycle use.

Pharmaceutical — generic: Generic exemestane 25mg through pharmacy is substantially cheaper — $30–$80 for 30 tablets depending on pharmacy and discount cards (GoodRx, etc.). Some men obtain generic exemestane through telehealth TRT clinics when estrogen management is included in their protocol.

Research chemical — tablet: RC exemestane tablets: $0.50–$2.00 per 25mg tablet depending on quantity and supplier. A 30-tab bottle typically runs $25–$60. Price alone is not a quality indicator — some of the cheapest suppliers have published COAs; some expensive ones do not.

Research chemical — liquid: Liquid exemestane (typically 12.5mg/mL or 25mg/mL) is common in RC markets. Dosing accuracy with liquids depends on measurement precision — a 1mL oral syringe is more reliable than eyeballing a dropper. Liquid can degrade faster than tablet form if storage conditions are poor.

Beyond pharmaceutical and RC categories, exemestane for sale also appears through underground lab (UGL) channels — typically the same suppliers providing anabolic steroids. UGL exemestane is manufactured in unregulated facilities, generally lacks any third-party testing, and quality consistency varies by batch.

The practical difference between RC and UGL:

For estrogen control on cycle, dosing accuracy matters. An AI that is 50% underdosed produces different blood work results than one that is accurately dosed. This is one reason men who use RC exemestane and have access to blood work sometimes find their response does not match expected protocol outcomes.

The reason aromasin source quality receives more attention than, for example, testosterone source quality is that the therapeutic window for an AI is narrower. If your testosterone is 15% underdosed, you get slightly less anabolic effect. If your exemestane is 50% underdosed, your E2 runs high and you think your AI dose is insufficient. If it is 50% overdosed, you crash estrogen trying to run what you believe is a standard dose.

Blood work is the calibration tool. If you are running the standard aromasin dosage on 500mg test — 12.5mg EOD — and E2 is not responding as expected, inconsistent product potency is one of the first variables to consider before adjusting the protocol.

Getting labs 4–5 weeks into a cycle and comparing E2 results to the expected range for your protocol tells you whether your exemestane is performing as labeled.

For men who want pharmaceutical-grade exemestane legally:

Aromasin.org is an independent educational resource. We are not affiliated with Pfizer, any pharmaceutical manufacturer, or healthcare provider. This content is for informational purposes only and does not constitute medical advice.